To find out more about a company click on the company name to see a brief profile.
Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
Immunotherapy Cancer Drug Race Speeds Up After Medical Meeting
(Morningstar/Dow Jones Newswires) June 6, 2013 - A promising new class of experimental drugs that unleash the body's immune system against tumors stole the show at a just-concluded meeting of cancer doctors.
read article 
Few Access Internet Help for Colonoscopy Prep
(Reuters Health) June 6, 2013 - Despite reminders, people scheduled for a colonoscopy didn't access an Internet video designed to educate them about proper preparation for the screening, in a new study.
read article
Court Says Some Morning-After Pills Must Be Available OTC Now
(NPR/Shots blog) June 5, 2013 - A federal appeals court has dealt the Obama administration yet another blow in its quest to keep at least some age restrictions on the sale of emergency contraceptive pills.
read article
New Research Suggests Declining Rate of Treatment Discoveries
(Columbia University Medical Center) June 3, 2013 - Recommends greater emphasis on comparing the effectiveness of established treatments.
read press release
New Healthcare Model Cut Even More Costs in Year Two: Insurer
(Reuters) June 6, 2013 - The nation's largest experiment in delivering medical care in an innovative way has reduced costs and improved the quality of care even more in its second year than in its first, according to the insurance company behind it.
read article
CytomX Announces Global Strategic Collaboration with Pfizer to Develop and Commercialize Multiple Probody™-Drug Conjugates in Oncology
(MarketWatch) June 6, 2013 – CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody™-Drug Conjugates (PDCs).
read article
FDA Approves Multi-Center Pivotal Trial of New Treatment for Chemotherapy-Related Hair Loss
(Dignitana) June 5, 2013 — Dignitana, a world leader in medical scalp-cooling technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and is now free to initiate a highly anticipated multi-center, pivotal trial of the patented DigniCap® System.
read corporate press release
CMS to Cover Anti-Nausea Regimen for Chemotherapy Patients
(ACCC) May 31, 2013 - The Centers for Medicare & Medicaid Services on May 29, 2013, issued a final Decision Memo for Aprepitant for Chemotherapy-Induced Emesis (CAG-00248R) expanding coverage of anti-nausea and vomiting therapy for beneficiaries undergoing chemotherapy.
read article
Radiation Oncology Resources, Inc. Signs Multi-Year Agreement to Provide The US Oncology Network its ROQS Quality System
(The US Oncology Network) June 6, 2013 - Radiation Oncology Resources, Inc. (ROR) announced today a multi-year agreement with McKesson Specialty Health to implement a proprietary Radiation Oncology Quality System (ROQSSM) Program at practices across the country that are affiliated with The US Oncology Network.
read corporate press release
ASCO Joins a Global Alliance to Enable Responsible Sharing of Genomic and Clinical Data
(ASCO) June 6, 2013 - ASCO has joined more than 70 leading health care, research, and disease advocacy organizations from around the world in taking the first steps to form an international alliance dedicated to enabling secure sharing of genomic and clinical data.
read press release
Aveo's Future Depends on Triple-Negative Breast Cancer
(TheStreet) June 6, 2013 - Aveo Oncology will succeed or fail depending on the potential for tivozanib to treat triple-negative breast cancer.
read article
Is There A Smart Way To Use The New Oncotype Prostate Cancer Test?
(Forbes) June 5, 2013 - On May 8th, the makers of the oncotype DX Prostate Cancer Test presented results of a large study demonstrating that their test can help men decide whether their prostate cancer carries a low enough risk of progression to forgo surgical or radiation therapy, two treatments that typically eradicate prostate cancers but also cause most men to experience impotence and incontinence.
read article
Checkpoint Charlie
(The Economist) June 8, 2013 - THE lexicon of oncology is filled with military metaphors: the war on cancer, aggressive tumours, magic bullets.
read article
Cytomegalovirus Might Speed Brain Cancer Growth
(OSUCCC - James) June 4, 2013 - A virus that infects most Americans but that usually remains dormant in the body might speed the progression of an aggressive form of brain cancer when particular genes are shut off in tumor cells, new research shows.
read press release
BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for Treatment of Leukemia
(DailyFinance) June 6, 2013 - BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia (AML).
read article
Cancer: Why Some Stem Cells Cause Tumors
(GEN News) June 4, 2013 - Understanding how single stem cells are corrupted to cause tumors could be a boon to scientists studying cancers suspected to have a stem cell origin.
read article
Rural Living Presents Health Challenges for Cancer Survivors
(Wake Forest Baptist) June 5, 2013 - Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
read press release
New Disease-to-Drug Genetic Matching Puts Snowboarder Back on Slopes
(UCCC/In the Clinic blog) June 5, 2013 - A recent article in the New England Journal of Medicine describes genetic testing of a rare blood cancer called atypical chronic neutrophilic leukemia (CNL) that revealed a new mutation present in most patients with the disease.
read article
Cancer Clinics Sequestration: Obama Administration Tells Congress It Can't Stop The Cuts
(Huffington Post) June 5, 2013 - The federal government does not have the power to stop federal budget sequestration cuts to cancer treatments for certain Medicare patients, the Centers for Medicare and Medicaid Services has told Congress.
read article
FDA Approves Lenalidomide for Mantle Cell Lymphoma
(ASH) June 5, 2013 - On June 5, 2013, the U. S. Food and Drug Administration approved lenalidomide capsules (REVLIMID, Celgene Corporation), for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
read article
Novartis Says Study Shows Gilenya Benefits Patients with MS
(Reuters) June 5, 2013 - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease.
read article
Biocon Seeks Partner to Sell Rival Drug to J&J’s Stelara
(Bloomberg) June 5, 2013 - Biocon Ltd., India’s largest publicly traded biotechnology company, is in talks with U.S. drugmakers to co-develop and sell a psoriasis treatment that may rival Johnson & Johnson’s Stelara.
read article
Docs Have Trouble Meeting Electronic Record Goals
(Reuters) June 5, 2013 - Despite the U.S. government offering hefty financial incentives to doctors for using electronic records to assess the care they provide, a new study says few doctors met the program's criteria last year.
read article
Accord Aims to Create Global Trove of Genetic Data
(New York Times) June 5, 2013 - Seventy medical, research and advocacy organizations active in 41 countries and including the National Institutes of Health announced Wednesday that they have agreed to create an organized way to share genetic and clinical information.
read article
Komen Cancels 3-Day Walk in District, Six Other Cities in 2014
(Washington Post) June 4, 2013 - The Susan G. Komen foundation canceled its signature 3-Day walk in Washington and six other cities next year, slashing the number of the fundraising events by half, as participation continues to drop more than a year after a funding controversy involving Planned Parenthood.
read article (free registration required)